-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Plus Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Plus Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $925K, a 2791% increase year-over-year.
- Plus Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.77M.
- Plus Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $5K.
- Plus Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$563K, a 37.9% increase from 2021.
- Plus Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$907K, a 168% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)